Viemed Healthcare, Inc.
NASDAQ:VMD
7.39 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 186.364 | 138.832 | 117.062 | 131.309 | 80.256 | 65.271 | 46.928 | 31.356 | 34.601 | 23.289 |
| Cost of Revenue
| 72.929 | 54.152 | 43.652 | 51.198 | 24.25 | 16.689 | 12.313 | 12.497 | 7.82 | 3.856 |
| Gross Profit
| 113.435 | 84.68 | 73.41 | 80.111 | 56.006 | 48.582 | 34.615 | 18.859 | 26.781 | 19.433 |
| Gross Profit Ratio
| 0.609 | 0.61 | 0.627 | 0.61 | 0.698 | 0.744 | 0.738 | 0.601 | 0.774 | 0.834 |
| Reseach & Development Expenses
| 2.833 | 2.696 | 2.11 | 1.083 | 0.848 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 93.733 | 73.363 | 60.043 | 57.711 | 45.267 | 30.681 | 20.247 | 13.769 | 0 | 0 |
| Selling & Marketing Expenses
| 1.171 | -5.202 | 0 | 0 | 0 | 0.268 | 0 | 0 | 0 | 0 |
| SG&A
| 94.904 | 73.363 | 60.043 | 57.711 | 45.267 | 30.949 | 20.247 | 13.769 | 16.743 | 9.561 |
| Other Expenses
| 0.1 | 0.023 | -0.771 | -3.136 | 0.671 | -0.071 | 0.402 | 0.332 | 0 | 0 |
| Operating Expenses
| 97.637 | 76.082 | 61.382 | 55.658 | 46.786 | 31.537 | 20.649 | 14.101 | 16.743 | 9.932 |
| Operating Income
| 15.797 | 8.252 | 11.58 | 26.781 | 8.747 | 17.045 | 8.824 | 0.383 | 10.038 | 9.487 |
| Operating Income Ratio
| 0.085 | 0.059 | 0.099 | 0.204 | 0.109 | 0.261 | 0.188 | 0.012 | 0.29 | 0.407 |
| Total Other Income Expenses Net
| -1.143 | 0.738 | 0.923 | -0.418 | 0.049 | -6.525 | -5.503 | -4.326 | -0.08 | -0.034 |
| Income Before Tax
| 14.655 | 8.99 | 12.503 | 26.363 | 8.796 | 10.339 | 8.191 | 0.109 | 9.958 | 9.453 |
| Income Before Tax Ratio
| 0.079 | 0.065 | 0.107 | 0.201 | 0.11 | 0.158 | 0.175 | 0.003 | 0.288 | 0.406 |
| Income Tax Expense
| 4.224 | 2.768 | 3.377 | -5.167 | 0.271 | 0.162 | 0.015 | -1.119 | 1.031 | 0 |
| Net Income
| 10.243 | 6.222 | 9.126 | 31.53 | 8.525 | 10.177 | 8.176 | 1.228 | 8.927 | 9.453 |
| Net Income Ratio
| 0.055 | 0.045 | 0.078 | 0.24 | 0.106 | 0.156 | 0.174 | 0.039 | 0.258 | 0.406 |
| EPS
| 0.27 | 0.15 | 0.23 | 0.86 | 0.23 | 0.27 | 0.22 | 0.032 | 0.24 | 1.58 |
| EPS Diluted
| 0.26 | 0.15 | 0.22 | 0.82 | 0.22 | 0.26 | 0.22 | 0.032 | 0.24 | 1.58 |
| EBITDA
| 38.09 | 24.574 | 23.788 | 34.126 | 15.62 | 20.828 | 16.509 | 6.182 | 10.993 | 9.872 |
| EBITDA Ratio
| 0.204 | 0.177 | 0.203 | 0.26 | 0.195 | 0.319 | 0.352 | 0.197 | 0.318 | 0.424 |